United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $881,922,152.25
- Sept. 4, 2025
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 11, 2015 | CEO | 2,211 | $147.29 | Sell | $325,658.19 | |
Feb. 10, 2015 | COO | 4,000 | $146.68 | Sell | $586,720.00 | |
Feb. 10, 2015 | CEO | 10,000 | $146.68 | Sell | $1,466,800.00 | |
Feb. 9, 2015 | CEO | 2,592 | $143.32 | Sell | $371,485.44 | |
Feb. 5, 2015 | CFO | 10,000 | $141.92 | Sell | $1,419,200.00 | |
Feb. 5, 2015 | Director | 3,000 | $140.41 | Sell | $421,230.00 | |
Feb. 5, 2015 | EVP | 6,000 | $141.92 | Sell | $851,520.00 | |
Feb. 5, 2015 | CEO | 11,773 | $141.07 | Sell | $1,660,817.11 | |
Feb. 3, 2015 | COO | 4,000 | $141.99 | Sell | $567,960.00 | |
Feb. 3, 2015 | CEO | 10,000 | $141.99 | Sell | $1,419,900.00 | |
Jan. 29, 2015 | CEO | 9,662 | $143.29 | Sell | $1,384,467.98 | |
Jan. 28, 2015 | CEO | 2,211 | $145.49 | Sell | $321,678.39 | |
Jan. 27, 2015 | CEO | 10,000 | $147.19 | Sell | $1,471,900.00 | |
Jan. 27, 2015 | COO | 4,000 | $147.19 | Sell | $588,760.00 | |
Jan. 26, 2015 | CEO | 2,592 | $145.89 | Sell | $378,146.88 | |
Jan. 22, 2015 | CEO | 11,873 | $146.76 | Sell | $1,742,481.48 | |
Jan. 20, 2015 | CEO | 2,592 | $145.06 | Sell | $375,995.52 | |
Jan. 20, 2015 | COO | 4,000 | $146.48 | Sell | $585,920.00 | |
Jan. 15, 2015 | EVP | 6,000 | $137.84 | Sell | $827,040.00 | |
Jan. 15, 2015 | CEO | 9,662 | $137.51 | Sell | $1,328,621.62 | |
Jan. 15, 2015 | CFO | 22,500 | $137.84 | Sell | $3,101,400.00 | |
Jan. 14, 2015 | CEO | 2,211 | $135.18 | Sell | $298,882.98 | |
Jan. 13, 2015 | COO | 3,000 | $134.71 | Sell | $404,130.00 | |
Jan. 13, 2015 | CEO | 10,000 | $134.71 | Sell | $1,347,100.00 | |
Jan. 12, 2015 | CEO | 2,592 | $132.00 | Sell | $342,144.00 | |
Jan. 8, 2015 | Director | 5,000 | $128.13 | Sell | $640,650.00 | |
Jan. 8, 2015 | CEO | 9,662 | $128.31 | Sell | $1,239,731.22 | |
Jan. 7, 2015 | CEO | 2,211 | $126.04 | Sell | $278,674.44 | |
Jan. 6, 2015 | CEO | 7,500 | $124.93 | Sell | $936,975.00 | |
Jan. 6, 2015 | COO | 3,000 | $124.93 | Sell | $374,790.00 | |
Jan. 5, 2015 | CEO | 2,592 | $126.88 | Sell | $328,872.96 | |
Jan. 2, 2015 | CEO | 9,662 | $126.53 | Sell | $1,222,532.86 | |
Jan. 2, 2015 | EVP | 6,000 | $127.73 | Sell | $766,380.00 | |
Jan. 2, 2015 | Director | 3,000 | $129.25 | Sell | $387,750.00 | |
Dec. 31, 2014 | CEO | 2,211 | $131.35 | Sell | $290,414.85 | |
Dec. 30, 2014 | CEO | 10,000 | $130.80 | Sell | $1,308,000.00 | |
Dec. 29, 2014 | CEO | 2,592 | $131.75 | Sell | $341,496.00 | |
Dec. 26, 2014 | CEO | 9,662 | $131.85 | Sell | $1,273,934.70 | |
Dec. 24, 2014 | CEO | 2,211 | $130.35 | Sell | $288,203.85 | |
Dec. 23, 2014 | COO | 10,000 | $127.82 | Sell | $1,278,200.00 | |
Dec. 22, 2014 | CEO | 2,592 | $133.45 | Sell | $345,902.40 | |
Dec. 19, 2014 | Director | 1,500 | $131.47 | Sell | $197,205.00 | |
Dec. 18, 2014 | EVP | 10,750 | $130.03 | Sell | $1,397,822.50 | |
Dec. 18, 2014 | CFO | 10,000 | $131.11 | Sell | $1,311,100.00 | |
Dec. 18, 2014 | CEO | 9,662 | $129.06 | Sell | $1,246,977.72 | |
Dec. 17, 2014 | CEO | 2,211 | $126.04 | Sell | $278,674.44 | |
Dec. 15, 2014 | CEO | 2,592 | $129.75 | Sell | $336,312.00 | |
Dec. 11, 2014 | CEO | 9,662 | $130.98 | Sell | $1,265,528.76 | |
Dec. 10, 2014 | CEO | 2,211 | $132.77 | Sell | $293,554.47 | |
Dec. 9, 2014 | COO | 10,000 | $134.80 | Sell | $1,348,000.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Christopher Patusky, Paul Mahon, David Zaccardelli, Michael Benkowitz, Richard Giltner, Nilda Mesa, James Edgemond, Tommy G Thompson, Louis W Sullivan, Judy D Olian, Paul A. Mahon, Ray Kurzweil, DWEK RAYMOND, MAHON PAUL A, Louis Sullivan, R Paul Gray, Judy D. Olian, and Tommy G. Thompson
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Sept. 4, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.